Immunic, Inc. (IMUX) Financials
IMUX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 54.3 million | 25.4 million |
2023-09-30 | 67.0 million | 18.6 million |
2023-06-30 | 88.7 million | 19.5 million |
2023-03-31 | 108.9 million | 17.7 million |
IMUX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -14.2 million | 1.6 million |
2023-09-30 | -17.4 million | 1.7 million |
2023-06-30 | -20.0 million | 1.8 million |
2023-03-31 | -19.6 million | 2.0 million |
IMUX Net Income
No data available :(
IMUX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 46.7 million | - | 1.3 million |
2023-09-30 | 59.7 million | - | 1.5 million |
2023-06-30 | 77.3 million | - | 1.9 million |
2023-03-31 | 97.1 million | - | 1.4 million |
IMUX Shares Outstanding
IMUX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 165000 | 19.3 million | 7.9 million | 3.8 million |
2023-09-30 | 44000 | 19.8 million | 3.8 million | - |
2023-06-30 | 21000 | 21.2 million | 3.8 million | - |
2023-03-31 | 104000 | 23.0 million | 4.3 million | - |
IMUX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | - |
2023-09-30 | - | 34000 |
2023-06-30 | - | 22000 |
2023-03-31 | - | 32000 |
IMUX
Price: $1.37
52 week price:
Earnings Per Share: -2.11 USD
P/E Ratio: -0.38
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 562646
Market Capitalization: 116.0 million